HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer [Corrigendum]
Bretoni A, Ferrario L, Foglia E. Clinicoecon Outcomes Res. 2019;11:283–300.The authors of this paper have advised us that there is a typographical error in one of the headings in Table 4. Table 4 occupies two pages and while being continued from page 292 onto page 293, a wrong table header...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-08-01
|
| Series: | ClinicoEconomics and Outcomes Research |
| Online Access: | https://www.dovepress.com/corrigendum-hta-and-innovative-treatments-evaluation-the-case-of--peer-reviewed-article-CEOR |
| Summary: | Bretoni A, Ferrario L, Foglia E. Clinicoecon Outcomes Res. 2019;11:283–300.The authors of this paper have advised us that there is a typographical error in one of the headings in Table 4. Table 4 occupies two pages and while being continued from page 292 onto page 293, a wrong table header was recorded. The table heading “Effectiveness profile” should instead be replaced by “Equity aspects” on page 293.Read the original article |
|---|---|
| ISSN: | 1178-6981 |